Journal of Urology, The

Journal

Publication Venue For

  • Re: Activities of Calcium-Related Ion Channels during the Formation of Kidney Stones in an Infection-Induced Urolithiasis Rat Model.  203:246-247. 2020
  • Re: Exosomes from miR-20b-3p-Overexpressing Stromal Cells Ameliorate Calcium Oxalate Deposition in Rat Kidney.  203:246. 2020
  • Re: Metabolomic Profiling of Oxalate-Degrading Probiotic Lactobacillus acidophilus and Lactobacillus gasseri.  203:247-248. 2020
  • Re: Nephrolithiasis after Bariatric Surgery: A Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy.  203:247. 2020
  • Editorial Comment.  203:199. 2020
  • Re: Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.  203:24-25. 2020
  • Re: An Easy Risk Stratification to Recommend the Optimal Patients with 2-3 cm Kidney Stones to Receive Retrograde Intrarenal Surgery or Mini-Percutaneous Nephrolithotomy.  203:26-27. 2020
  • Re: Chlorthalidone is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.  203:26. 2020
  • Re: Identification of Ureteral Stones at Reduced Radiation Exposure: A Pilot Study Comparing Conventional versus Digital Low-Dosage Linear Slot Scanning (Lodox®) Radiography.  203:25-26. 2020
  • Re: Inhibition of Urinary Stone Disease by a Multi-Species Bacterial Network Ensures Healthy Oxalate Homeostasis.  203:25. 2020
  • Re: Evaluation of Inactive Matrix-Gla-Protein (MGP) as a Biomarker for Incident and Recurrent Kidney Stones.  202:1092. 2019
  • Re: Metabolic Consequences of Cystinuria.  202:1091-1093. 2019
  • Re: Nonrenal Systemic Arterial Calcification Predicts the Formation of Kidney Stones.  202:1092-1093. 2019
  • Re: The Impact of Potassium Citrate Therapy in the Natural Course of Medullary Sponge Kidney with Associated Nephrolithiasis.  202:1091-1092. 2019
  • Editorial Comment.  202:1014. 2019
  • Re: A Rock-Boring and Rock-Ingesting Freshwater Bivalve (Shipworm) from the Philippines.  202:862-863. 2019
  • Re: Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.  202:863. 2019
  • Re: Reduction in Urinary Oxalate Excretion in Mouse Models of Primary Hyperoxaluria by RNA Interference Inhibition of Liver Lactate Dehydrogenase Activity.  202:861-862. 2019
  • Re: Stiripentol Protects against Calcium Oxalate Nephrolithiasis and Ethylene Glycol Poisoning.  202:862. 2019
  • Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.  202:710-716. 2019
  • Re: Association of Urinary Oxalate Excretion with the Risk of Chronic Kidney Disease Progression.  202:654-655. 2019
  • Re: Increased Production and Reduced Urinary Buffering of Acid in Uric Acid Stone Formers is Ameliorated by Pioglitazone.  202:655-656. 2019
  • Re: Long-Term Adherence to Medications in Secondary Prevention of Urinary Tract Stones.  202:656-657. 2019
  • Re: Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.  202:656. 2019
  • Re: A Prospective Study Analyzing the Association between High-Grade Ureteral Access Sheath Injuries and the Formation of Ureteral Strictures.  202:454. 2019
  • Re: Hydroxycitrate: A Potential New Therapy for Calcium Urolithiasis.  202:454-455. 2019
  • Re: In Vitro Bactericidal Effect of Ho:YAG Laser and Pneumatic Lithotripsy on Ureteral Stones Colonized with Escherichia coli and Enterococcus faecalis.  202:453-454. 2019
  • Re: Outcomes of Endourologic Interventions in Patients with Preoperative Funguria.  202:453. 2019
  • Re: Association between Dietary Pattern and Metabolic Disorders in Children and Adolescents with Urolithiasis.  202:205-206. 2019
  • Re: Fecal Transplant Modifies Urine Chemistry Risk Factors for Urinary Stone Disease.  202:205. 2019
  • Re: Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.  202:204-205. 2019
  • Re: Systemic Succinate Homeostasis and Local Succinate Signaling Affect Blood Pressure and Modify Risks for Calcium Oxalate Lithogenesis.  202:203-204. 2019
  • Re: Clinical Aspects of the Phosphate Transporters NaPi-IIa and NaPi-IIb: Mutations and Disease Associations.  202:26. 2019
  • Re: External Physical Vibration Lithecbole Facilitating the Expulsion of Upper Ureteric Stones 1.0-2.0 cm after Extracorporeal Shock Wave Lithotripsy: A Prospective Randomized Trial.  202:27. 2019
  • Re: Novel Mutations Associated with Inherited Human Calcium-Sensing Receptor Disorders: A Clinical Genetic Study.  202:26. 2019
  • Re: Urine Proteomic Profiling in Patients with Nephrolithiasis and Cystinuria.  202:25. 2019
  • Baseline Urinary Tract Imaging in Infants Enrolled in the UMPIRE Protocol for Children with Spina Bifida.  201:1193-1198. 2019
  • Editorial comment.  201:1048. 2019
  • Editorial comment.  201:1048. 2019
  • Editorial comment.  201:1049. 2019
  • Editorial comment.  201:1047-1048. 2019
  • Re: CRISPR/Cas9-Mediated Glycolate Oxidase Disruption is an Efficacious and Safe Treatment for Primary Hyperoxaluria Type i.  201:853-854. 2019
  • Re: Sirtuin 3 Suppresses the Formation of Renal Calcium Oxalate Crystals through Promoting M2 Polarization of Macrophages.  201:852-853. 2019
  • Re: The Effect of Lemonade and Diet Lemonade upon Urinary Parameters Affecting Calcium Urinary Stone Formation.  201:853. 2019
  • Re: The Impact of Dust and Confinement on Fragmentation of Kidney Stones by Shockwave Lithotripsy in Tissue Phantoms.  201:854. 2019
  • Re: Claudin-14 Gene Polymorphisms and Urine Calcium Excretion.  201:662. 2019
  • Re: Geobiology reveals how human kidney stones dissolve in vivo.  201:663-664. 2019
  • Re: Hyponatremia and the Risk of Kidney Stones: A Matched Case-Control Study in a Large U.S. Health System.  201:661. 2019
  • Re: Variation in national opioid prescribing patterns following surgery for kidney stones.  201:662-663. 2019
  • Re: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: An Evidence Review for the U.S. Preventive Services Task Force.  201:663. 2019
  • Re: Assessing cancer progression and stable disease after neoadjuvant chemotherapy for organ-confined muscle-invasive bladder cancer.  201:441. 2019
  • Re: Diagnostic Accuracy of Third-Generation Dual-Source Dual-Energy CT:.  201:437. 2019
  • Re: Incomplete Distal Renal Tubular Acidosis and Kidney Stones.  201:436-437. 2019
  • Re: Outcomes of Long-Term Follow-up of Asymptomatic Renal Stones and Prediction of Stone Related Events.  201:438. 2019
  • Re: Safety of Calcium and Vitamin D Supplements, a Randomized Controlled Trial.  201:436. 2019
  • Re: Variation in kidney stone composition within the United States.  201:437-438. 2019
  • Re: Calcium Oxalate Differentiates Human Monocytes into Inflammatory M1 Macrophages.  201:222-223. 2019
  • Re: Metabolic Profile and Impact of Diet in Patients with Primary Hyperoxaluria.  201:223-224. 2019
  • Re: The Ability of a Limited Metabolic Assessment to Identify Pediatric Stone Formers with Metabolic Abnormalities.  201:223. 2019
  • Re: Urinary Proteomics Reveals Association between Pediatric Nephrolithiasis and Cardiovascular Disease.  201:224. 2019
  • Editorial comment.  201:26. 2019
  • Editorial comment.  201:24. 2019
  • Editorial comment.  201:25. 2019
  • Editorial comment.  201:24-25. 2019
  • Editorial Comment.  200:1047. 2018
  • Re: CT-Based Diagnosis of Low Vertebral Bone Mineral Density is Associated with Hypercalciuria and Hypocitraturia on Opportunistic Imaging.  200:939-940. 2018
  • Re: Effect of Tamsulosin on Passage of Symptomatic Ureteral Stones: A Randomized Clinical Trial.  200:938-941. 2018
  • Re: Nephrolithiasis and Nephrocalcinosis from Topiramate Therapy in Children with Epilepsy.  200:940. 2018
  • Re: Understanding the Gut-Kidney Axis in Nephrolithiasis: An Analysis of the Gut Microbiota Composition and Functionality of Stone Formers.  200:940-941. 2018
  • Re: Mini vs Standard Percutaneous Nephrolithotomy for Renal Stones: A Comparative Study.  200:693. 2018
  • Re: The Transgluteal Approach to Shockwave Lithotripsy to Treat Distal Ureter Stones: A Prospective, Randomized, and Multicenter Study.  200:693-694. 2018
  • Re: Two are no Different than One: Ureteral Duplication Appears to Have no Effect on Ureteroscopy Outcomes.  200:692-693. 2018
  • Re: Use of the Ureteral Access Sheath during Ureteroscopy: A Systematic Review and Meta-Analysis.  200:692-694. 2018
  • Re: A Rapid Screening of a Recurrent CYP24A1 Pathogenic Variant Opens the Way to Molecular Testing for Idiopathic Infantile Hypercalcemia (IIH).  200:492-494. 2018
  • Re: Comparison of Flexible Ureteroscopy Damage Rates for Lower Pole Renal Stones by Laser Fiber Type.  200:493-494. 2018
  • Re: Evaluating Factors That Dictate Struvite Stone Composition: A Multi-Institutional Clinical Experience from the EDGE Research Consortium.  200:493. 2018
  • Re: Three-Dimensional Evaluation of Perirenal Fat Volume in Patients with Nephrolithiasis.  200:493. 2018
  • Bladder Management and Continence Outcomes in Adults with Spina Bifida: Results from the National Spina Bifida Patient Registry, 2009 to 2015.  200:187-194. 2018
  • Editorial Comment.  200:112-113. 2018
  • Re: Calcium Tartrate Tetrahydrate, Case Report of a Novel Human Kidney Stone.  199:1392. 2018
  • Re: Dent Disease.  199:1392. 2018
  • Re: Polymorphisms in Renal Ammonia Metabolism Genes Correlate with 24-Hour Urine pH.  199:1391. 2018
  • Re: Sporadic Primary Hyperparathyroidism and Stone Disease: A Comprehensive Metabolic Evaluation before and after Parathyroidectomy.  199:1390-1392. 2018
  • Re: Subcapsular Splenic Urinoma and Splenorenal Fistula: A New Complication of Percutaneous Nephrolithotomy.  199:1391-1392. 2018
  • Interrater Reliability in Interpretation of Neuropathic Pediatric Urodynamic Tracings: An Expanded Multicenter Study.  199:1337-1343. 2018
  • Re: Changes in Urinary Risk Profile after Short-Term Low Sodium and Low Calcium Diet in Recurrent Swiss Kidney Stone Formers.  199:1107. 2018
  • Re: Composition of Urinary Calculi in Infants: A Report from an Endemic Country.  199:1105-1107. 2018
  • Re: Microbiota Diversification and Crash Induced by Dietary Oxalate in the Mammalian Herbivore Neotoma albigula.  199:1106. 2018
  • Re: Multiple Endocrine Neoplasia Type 1.  199:1107. 2018
  • Re: Oxalate Nephropathy following Vitamin C Intake within Intensive Care Unit.  199:1106. 2018
  • Re: Associating Mutations Causing Cystinuria with Disease Severity with the Aim of Providing Precision Medicine.  199:887-888. 2018
  • Re: Dual Energy CT Kidney Stone Differentiation in Photon Counting Computed Tomography.  199:888. 2018
  • Re: Oxalobacter formigenes-Associated Host Features and Microbial Community Structures Examined Using the American Gut Project.  199:888. 2018
  • Re: Plasma Oxalate in Relation to eGFR in Patients with Primary Hyperoxaluria, Enteric Hyperoxaluria and Urinary Stone Disease.  199:887. 2018
  • Editorial Comment.  199:705. 2018
  • Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy.  199:719-725. 2018
  • Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance.  199:438-444. 2018
  • Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features.  199:445-452. 2018
  • Re: Effectiveness of Treatment Modalities on Kidney Stone Recurrence.  199:337-338. 2018
  • Re: Evidence of Disordered Calcium Metabolism in Adolescent Girls with Type 1 Diabetes: An Observational Study Using a Dual-Stable Calcium Isotope Technique.  199:335-338. 2018
  • Re: Stone Growth Patterns and Risk for Surgery among Children Presenting with Hypercalciuria, Hypocitraturia and Cystinuria as Underlying Metabolic Causes of Urolithiasis.  199:336. 2018
  • Re: Surgery for Primary Hyperparathyroidism: Adherence to Consensus Guidelines in an Academic Health System.  199:336-337. 2018
  • Re: saRNA-Mediated Activation of TRPV5 Reduces Renal Calcium Oxalate Deposition in Rat via Decreasing Urinary Calcium Excretion.  199:337. 2018
  • A Behavioral Weight Loss Program and Nonurinary Incontinence Lower Urinary Tract Symptoms in Overweight and Obese Women with Urinary Incontinence: A Secondary Data Analysis of PRIDE.  199:215-222. 2018
  • Bladder Reconstruction Rates Differ among Centers Participating in National Spina Bifida Patient Registry.  199:268-273. 2018
  • Re: Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones.  199:22-23. 2018
  • Re: Safety and Effectiveness of a Longer Focal Beam and Burst Duration in Ultrasonic Propulsion for Repositioning Urinary Stones and Fragments.  199:21-23. 2018
  • Re: Use of Medical Expulsive Therapy in Children: An Assessment of Nationwide Practice Patterns and Outcomes.  199:22. 2018
  • Re: A Prospective Randomized Comparison of Micropercutaneous Nephrolithotomy (Microperc) and Retrograde Intrarenal Surgery (RIRS) for the Management of Lower Pole Kidney Stones.  198:1203-1204. 2017
  • Re: Comparison of CROES, S.T.O.N.E, and Guy's Scoring Systems for the Prediction of Stone-Free Status and Complication Rates following Percutaneous Nephrolithotomy in Patients with Chronic Kidney Disease.  198:1204. 2017
  • Re: Vascular Disease and Kidney Stones: Abdominal Aortic Calcifications are Associated with Low Urine pH and Hypocitraturia.  198:1203-1204. 2017
  • Re: A Survey of Patient Preferences Regarding Medical Expulsive Therapy following the SUSPEND Trial.  198:975-976. 2017
  • Re: Effects of Juice Processing on Oxalate Contents in Carambola Juice Products.  198:974-976. 2017
  • Re: Oxalobacter formigenes Colonization Normalizes Oxalate Excretion in a Gastric Bypass Model of Hyperoxaluria.  198:974-975. 2017
  • Re: α-Lipoic Acid Treatment Prevents Cystine Urolithiasis in a Mouse Model of Cystinuria.  198:975. 2017
  • Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.  198:890-896. 2017
  • Re: A Multi-Institutional Study of Struvite Stones: Patterns of Infection and Colonization.  198:737. 2017
  • Re: Development of Endoscopic Diagnosis and Treatment for Chronic Unilateral Hematuria: 35 Years Experience.  198:738-739. 2017
  • Re: Primary SWL is an Efficient and Cost-Effective Treatment for Lower Pole Renal Stones between 10 and 20 mm in Size: A Large Single Center Study.  198:736-739. 2017
  • Re: Use of the Moses Technology to Improve Holmium Laser Lithotripsy Outcomes: A Preclinical Study.  198:738. 2017
  • Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications for Cystectomy in Bladder Cancer.  198:511-519. 2017
  • Re: CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients with CYP24A1 Mutations.  198:478. 2017
  • Re: Characterization of Urolithiasis in Patients following Lower Urinary Tract Reconstruction with Intestinal Segments.  198:479. 2017
  • Re: Uric Acid versus Non-Uric Acid Renal Stones: In Vivo Differentiation with Spectral CT.  198:477-479. 2017
  • Re: Urolithiasis in Inflammatory Bowel Disease and Bariatric Surgery.  198:478-479. 2017
  • Re: Multiple Sclerosis and Nephrolithiasis: A Matched-Case Comparative Study.  198:251-252. 2017
  • Re: Oxalate Content of Taro Leaves Grown in Central Vietnam.  198:251. 2017
  • Re: Stone Former Urine Proteome Demonstrates a Cationic Shift in Protein Distribution Compared to Normal.  198:250-252. 2017
  • Re: Use of Polymer Conjugates for the Intraperoxisomal Delivery of Engineered Humanalanine:Glyoxylate Aminotransferase as a Protein Therapy for Primary Hyperoxaluria Type I.  198:252. 2017
  • Re: Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.  198:138-139. 2017
  • Re: Outcomes of Percutaneous Nephrolithotomy in Spinal Cord Injury Patients as Compared to a Matched Cohort.  198:139-140. 2017
  • Re: Perirenal Hematoma after Ureteroscopy: A Systematic Review.  198:139. 2017
  • Re: Thiazide Treatment in Primary Hyperparathyroidism-A New Indication for an Old Medication?.  198:138-140. 2017
  • Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria.  197:1463. 2017
  • Re: Factors Associated with Compliance in Submitting 24-Hour Urine Collections in an Underserved Community.  197:1479. 2017
  • Re: High-Frequency Dusting versus Conventional Holmium Laser Lithotripsy for Intrarenal and Ureteral Calculi.  197:1478-1479. 2017
  • Re: Progress in Understanding the Genetics of Calcium-Containing Nephrolithiasis.  197:1478-1479. 2017
  • Re: RNA Interference in the Treatment of Renal Stone Disease: Current Status and Future Potentials.  197:1479. 2017
  • Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.  197:1487-1495. 2017
  • Re: Addition of Calcium Compounds to Reduce Soluble Oxalate in a High Oxalate Food System.  197:1296-1297. 2017
  • Re: An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.  197:1297-1298. 2017
  • Re: Calcium Oxalate Induces Renal Injury through Calcium-Sensing Receptor.  197:1297. 2017
  • Re: Vitamin D Deficiency is Prevalent among Idiopathic Stone Formers, but Does Correction Pose any Risk?.  197:1296-1298. 2017
  • Re: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.  197:736-737. 2017
  • Re: First Clinical Evaluation of a New Single-Use Flexible Ureteroscope (LithoVue™): A European Prospective Multicentric Feasibility Study.  197:737. 2017
  • Re: Hypercalcemia, Hypercalciuria, and Kidney Stones in Long-Term Studies of Vitamin D Supplementation: A Systematic Review and Meta-Analysis.  197:737. 2017
  • Re: Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.  197:736-737. 2017
  • Editorial Comment.  197:514. 2017
  • Re: Do Overweight and Obese Pediatric Stone Formers Have Differences in Metabolic Abnormalities Compared with Normal-Weight Stone Formers?.  197:518. 2017
  • Re: Molecular Modifiers Reveal a Mechanism of Pathological Crystal Growth Inhibition.  197:411-413. 2017
  • Re: Patients Attending Shared Medical Appointments for Metabolic Stone Prevention have Decreased Stone Risk Factors.  197:412. 2017
  • Re: Response of Germ-Free Mice to Colonization with O. formigenes and Altered Schaedler Flora.  197:412-413. 2017
  • Re: Best Stent Length Predicted by Simple CT Measurement Rather Than Patient Height.  197:171. 2017
  • Re: Can the Presence of Crystalluria Predict Stone Formation in Patients with Cystinuria?.  197:169-170. 2017
  • Re: Carbapenem-Resistant Enterobacteriaceae and Endoscopy: An Evolving Threat.  197:171-172. 2017
  • Re: Defining the Rate of Primary Ureteroscopic Failure in Unstented Patients: A Multi-Institutional Study.  197:171. 2017
  • Re: N-Glycosylation Critically Regulates Function of Oxalate Transporter SLC26A6 2017
  • Re: Pulsed versus Continuous Mode Fluoroscopy during PCNL: Safety and Effectiveness Comparison in a Case Series Study.  197:172. 2017
  • Re: The Use of Apnea During Ureteroscopy.  197:170. 2017
  • Re: Ureteric Stents on Extraction Strings: A Systematic Review of Literature.  197:170-172. 2017
  • Safety and Efficacy of En Bloc Renal Hilar Vascular Staple Ligation: A Meta-Analysis.  197:175-181. 2017
  • Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida.  196:1728-1734. 2016
  • Re: HMGB1/TLR4 Signaling Induces an Inflammatory Response following High-Pressure Renal Pelvic Perfusion in a Porcine Model.  196:1818-1819. 2016
  • Re: Intestinal Calcium Absorption among Hypercalciuric Patients with or without Calcium Kidney Stones.  196:1471-1472. 2016
  • Re: Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.  196:1586-1587. 2016
  • Re: Microbial Community Transplant Results in Increased and Long-Term Oxalate Degradation.  196:1586-1587. 2016
  • Re: Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.  196:1471-1472. 2016
  • SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.  196:1436-1444. 2016
  • Symptom Variability and Early Symptom Regression in the MAPP Study: A Prospective Study of Urological Chronic Pelvic Pain Syndrome.  196:1450-1455. 2016
  • Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC.  196:1129-1135. 2016
  • Re: Evaluation of Postoperative Hydronephrosis following Ureteroscopy in Pediatric Population: Incidence and Predictors.  196:1258-1259. 2016
  • Re: Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers.  196:1170-1171. 2016
  • Re: Risk of Recurrence of Idiopathic Calcium Kidney Stones: Analysis of Data from the Literature.  196:1171. 2016
  • Re: Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones.  196:1170-1171. 2016
  • Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I.  196:1153-1160. 2016
  • Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II.  196:1161-1169. 2016
  • Bladder Distension Increases Blood Flow in Pain Related Brain Structures in Subjects with Interstitial Cystitis.  196:902-910. 2016
  • Preoperative Urodynamic Parameters (Valsalva Leak Point Pressure and Maximum Urethral Closure Pressure), Urinary Collagen and Plasma Vitamin D Levels as Predictors of Mid Urethral Sling Surgery Outcome.  196:819-823. 2016
  • Re: Animal Experimental Study to Test Application of Intelligent Pressure Control Device in Monitoring and Control of Renal Pelvic Pressure during Flexible Ureteroscopy.  196:959. 2016
  • Re: Contemporary Trends in Percutaneous Nephrolithotomy in the United States: 1998-2011.  196:776. 2016
  • Re: Potassium Citrate Decreases Urine Calcium Excretion in Patients with Hypocitraturic Calcium Oxalate Nephrolithiasis.  196:775-776. 2016
  • Re: The Exposome for Kidney Stones.  196:775. 2016
  • 24-Hour Urinary Parameters in Overweight and Obese Children with Urolithiasis.  196:526-530. 2016
  • Re: Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis.  196:550-551. 2016
  • Re: Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence.  196:551. 2016
  • Re: Ways of Calcium Reabsorption in the Kidney.  196:451-452. 2016
  • Evaluation of Renal Function after Percutaneous Nephrolithotomy—Does the Number of Percutaneous Access Tracts Matter?.  196:131-136. 2016
  • Prospective Assessment of Radiation in Pediatric Urology: The Pediatric Urology Radiation Safety Evaluation Study.  196:202-206. 2016
  • Re: Glycolate Oxidase is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.  196:281-282. 2016
  • Re: Oxalate Contents of Commonly Used Chinese Medicinal Herbs.  196:137-138. 2016
  • Re: Oxalate Induces Breast Cancer.  196:282. 2016
  • Re: Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting prior to Kidney Failure.  196:137-138. 2016
  • Re: Characterization of Urinary Stone Composition by Use of Third-Generation Dual-Source Dual-Energy CT with Increased Spectral Separation.  195:1949-1950. 2016
  • Re: Detection of Different Kidney Stone Types: An Ex Vivo Comparison of Ultrashort Echo Time MRI to Reference Standard CT.  195:1949-1950. 2016
  • Re: The Role of Calbindin-D28k on Renal Calcium and Magnesium Handling during Treatment with Loop and Thiazide Diuretics.  195:1810. 2016
  • Re: Imaging and surgical utilization for pediatric cystinuria patients: A single-institution cohort study: Editorial comment.  195:1576-1577. 2016
  • Re: Impact of retrograde flexible ureteroscopy and intracorporeal lithotripsy on kidney functional outcomes: Editorial comment: Editorial comment.  195:1492-1493. 2016
  • Re: Modular flexible ureteroscopy and holmium laser lithotripsy for the treatment of renal and proximal ureteral calculi: A single-surgeon experience of 382 cases: Editorial comment.  195:1492-1493. 2016
  • Re: The efficacy of peritubal analgesic infiltration in postoperative pain following percutaneous nephrolithotomy - A prospective randomized controlled study: Editorial comment.  195:1493. 2016
  • A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer.  195:880-885. 2016
  • MP67-02 THE EFFECT OF ALANINE ON CELL VIABILITY AND AGT ACTIVITY IN TRANSFORMED CHINESE HAMSTER OVARY CELLS.  195:e881-e881. 2016
  • MP67-03 MITOCHONDRIAL IMPLICATIONS OF GLYCOLATE METABOLISM IN PRIMARY HYPEROXALURIA.  195:e881-e882. 2016
  • Re: Flexible Ureterorenoscopy and Laser Lithotripsy for the Treatment of Allograft Kidney Lithiasis.  195:1006. 2016
  • Re: Impact of Hours Worked by a Urologist prior to Performing Ureteroscopy on its Safety and Efficacy.  195:1006-1007. 2016
  • Re: Predictive Value of Leukocytosis for Infectious Complications after Percutaneous Nephrolithotomy.  195:1007. 2016
  • Re: Pyridoxamine and Pyridoxal are More Effective than Pyridoxine in Rescuing Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.  195:1170-1171. 2016
  • Salvage Percutaneous Nephrolithotomy: Analysis of Outcomes following Initial Treatment Failure.  195:977-981. 2016
  • Re: Alkali Replacement Raises Urinary Citrate Excretion in Patients with Topiramate-Induced Hypocitraturia.  195:659. 2016
  • Re: Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers.  195:658-659. 2016
  • Re: Do Kidney Stone Formers Have a Kidney Disease?.  195:658. 2016
  • Re: EAU Guidelines on Interventional Treatment for Urolithiasis.  195:659. 2016
  • Re: Can Sexual Intercourse be an Alternative Therapy for Distal Ureteral Stones? A Prospective, Randomized, Controlled Study: Editorial Comment: Editorial Comment.  195:383-384. 2016
  • Re: Effect of Demographics on Excretion of Key Urinary Factors Related to Kidney Stone Risk: Editorial Comment: Editorial Comment.  195:384. 2016
  • Re: Hyperoxaluria and Genitourinary Disorders in Children Ingesting Almond Milk Products: Editorial Comment.  195:478. 2016
  • Re: Medical Expulsive Therapy for Pediatric Urolithiasis: Systematic Review and Meta-Analysis: Editorial Comment.  195:478. 2016
  • Re: Stone Composition among First-Time Symptomatic Kidney Stone Formers in the Community: Editorial Comment.  195:383-384. 2016
  • Re: Clinically Insignificant Residual Fragments: Is it an Appropriate Term in Children? Editorial Comment.  195:170. 2016
  • Re: Flexible Ureteroscopic Laser Lithotripsy for Upper Urinary Tract Stone Disease in Patients with Spinal Cord Injury Editorial Comment.  195:105. 2016
  • Re: Surgical Management of Stone Disease in Patients with Primary Hyperoxaluria Editorial Comment.  195:104-105. 2016
  • Re: Ureteroscopic Management of Asymptomatic and Symptomatic Simple Parapelvic Renal Cysts Editorial Comment.  195:104-105. 2016
  • Re: Does stepwise voltage ramping protect the kidney from injury during extracorporeal shockwave lithotripsy? Results of a prospective randomized trial.  194:1652-1653. 2015
  • Re: Hypercalciuria may persist after successful parathyroid surgery and it is associated with parathyroid hyperplasia.  194:1652-1653. 2015
  • Re: Medical Expulsive Therapy in Adults with Ureteric Colic: A Multicentre, Randomised, Placebo-Controlled Trial.  194:1313-1314. 2015
  • Re: Feasibility of discriminating uric acid from non-uric acid renal stones using consecutive spatially registered low- and high-energy scans obtained on a conventional CT scanner.  194:1016-1017. 2015
  • Re: Surgical management of stone disease in patients with primary hyperoxaluria.  194:1014-1015. 2015
  • Genetic contributions to urgency urinary incontinence in women.  193:2020-2027. 2015
  • Re: Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.  193:2008-2010. 2015
  • Re: Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.  193:2008-2009. 2015
  • Re: Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events.  193:2009-2010. 2015
  • Re: The ROKS nomogram for predicting a second symptomatic stone episode.  193:2009. 2015
  • Re: Caffeine intake and the risk of kidney stones: Editorial comment.  193:1570-1571. 2015
  • MP34-04 INHIBITION OF GLYCOLATE OXIDASE REDUCES URINARY OXALATE EXCRETION IN A MOUSE MODEL OF PRIMARY HYPEROXALURIA TYPE 1.  193:e411-e411. 2015
  • Re: Do the residual fragments after shock wave lithotripsy affect the quality of life?.  193:1275-1276. 2015
  • Re: Management of calyceal diverticular calculi: A comparison of percutaneous nephrolithotomy and flexible ureterorenoscopy.  193:1275-1276. 2015
  • Re: Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria.  193:900-901. 2015
  • Re: Oxalate content of food: A tangled web.  193:897-898. 2015
  • Re: Ultrasonography versus computed tomography for suspected nephrolithiasis.  193:899-901. 2015
  • Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system.  193:558-564. 2015
  • 5-Year Longitudinal Followup after Retropubic and Transobturator Mid Urethral Slings.  193:203-210. 2015
  • A Prospective, Multi-Institutional Study of Flexible Ureteroscopy for Proximal Ureteral Stones Smaller than 2 cm.  193:165-169. 2015
  • A genomic algorithm for the molecular classification of common renal cortical neoplasms: Development and validation.  193:1479-1485. 2015
  • Bladder cancer mortality after spinal cord injury over 4 decades.  193:1923-1928. 2015
  • Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillance.  193:1943-1949. 2015
  • Comparison of Transvaginal and Retropubic Bladder Neck Closure with Suprapubic Catheter in Women.  193:196-202. 2015
  • Editorial Comment.  194:329-330. 2015
  • Editorial comment.  193:1811-1812. 2015
  • Gleason 6 prostate cancer: Translating biology into population health.  194:626-634. 2015
  • Grade Heterogeneity in Small Renal Masses: Potential Implications for Renal Mass Biopsy.  193:36-40. 2015
  • Increased Brain Gray Matter in the Primary Somatosensory Cortex is Associated with Increased Pain and Mood Disturbance in Patients with Interstitial Cystitis/Painful Bladder Syndrome.  193:131-137. 2015
  • Re: Adverse events resulting from lasers used in urology.  193:170. 2015
  • Re: Analysis of Commercial Kidney Stone Probiotic Supplements: Editorial Comment.  194:425-426. 2015
  • Re: Antimicrobial resistance patterns in cases of obstructive pyelonephritis secondary to stones: Editorial comment.  193:1571. 2015
  • Re: Asymptomatic lower pole small renal stones: Shock wave lithotripsy, flexible ureteroscopy, or observation? A prospective randomized trial.  194:144-145. 2015
  • Re: Biopsy Proven Medullary Sponge Kidney: Clinical Findings, Histopathology, and Role of Osteogenesis in Stone and Plaque Formation: Editorial Comment.  194:424-425. 2015
  • Re: CKD and its Risk Factors among Patients with Cystinuria.  194:1313-1314. 2015
  • Re: Clinical outcomes after ureteroscopic lithotripsy in patients who initially presented with urosepsis: Matched pair comparison with elective ureteroscopy: Editorial comment.  193:1571. 2015
  • Re: Comparison between extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy for treating large proximal ureteral stones: A meta-analysis.  194:1016-1017. 2015
  • Re: Demographics and Characterization of 10,282 Randall Plaque-Related Kidney Stones: A New Epidemic? Editorial Comment.  194:425. 2015
  • Re: Determinants of nephrostomy tube dislodgment after percutaneous nephrolithotomy.  194:144-145. 2015
  • Re: Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screening.  194:1015. 2015
  • Re: Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: A clinical practice guideline from the American college of physicians: Editorial comment.  193:1570-1571. 2015
  • Re: Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.  194:1506. 2015
  • Re: Effect of extrusion variables (temperature, moisture) on the antinutrient components of cereal brans.  194:1164. 2015
  • Re: Influence of saline on temperature profile of laser lithotripsy activation.  193:898. 2015
  • Re: Long-term urine biobanking: Storage stability of clinical chemical parameters under moderate freezing conditions without use of preservatives.  193:898. 2015
  • Re: Nomogram to predict uric acid kidney stones based on patient's age, BMI and 24-hour urine profiles: A multicentre validation.  194:1653. 2015
  • Re: Oxalobacter formigenes: Opening the Door to Probiotic Therapy for the Treatment of Hyperoxaluria: Editorial Comment.  194:424-425. 2015
  • Re: Paraplegia-quadriplegia independently increases all percutaneous nephrolithotomy complications: A comparative study using the modified clavien system.  194:1017. 2015
  • Re: Percutaneous nephrolithotomy in pelvic kidneys: Is the ultrasound-guided puncture safe?.  194:145. 2015
  • Re: Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.  193:1062. 2015
  • Re: Predicting an effective ureteral access sheath insertion: A bicenter prospective study.  193:1276. 2015
  • Re: Predicting urinary stone composition based on single-energy noncontrast computed tomography: the challenge of cystine.  193:170-171. 2015
  • Re: Prospective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.  194:1750. 2015
  • Re: Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of lapis judaicus.  193:897-898. 2015
  • Re: Safety, minimization, and awareness radiation training reduces fluoroscopy time during unilateral ureteroscopy.  193:171. 2015
  • Re: The G allele of CaSR R990G polymorphism increases susceptibility to urolithiasis and hypercalciuria: Evidences from a comprehensive meta-analysis.  194:1014. 2015
  • Re: Ultrasound acoustic shadow width is an accurate predictor of kidney stone size.  193:900. 2015
  • Re: Ureteroscopy for stone disease in the paediatric population - A systematic review.  193:1370. 2015
  • Re: Urine Proteomic Analysis in Cystinuric Children with Renal Stones.  194:1427. 2015
  • Re: Vascular calcification and bone mineral density in recurrent kidney stone formers.  194:1015. 2015
  • The artificial urinary sphincter is superior to a secondary transobturator male sling in cases of a primary sling failure.  194:1038-1042. 2015
  • The ohmmeter identifies the site of fluid leakage during artificial urinary sphincter revision surgery.  194:1043-1048. 2015
  • The role of image guided biopsy targeting in patients with atypical small acinar proliferation.  193:473-478. 2015
  • The role of magnetic resonance image guided prostate biopsy in stratifying men for risk of extracapsular extension at radical prostatectomy.  194:105-111. 2015
  • Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.  192:1642-1649. 2014
  • Re: Diet and risk of kidney stones in the oxford cohort of the european prospective investigation into cancer and nutrition (EPIC): Editorial comment.  192:1714-1715. 2014
  • GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.  192:1542-1548. 2014
  • Re: Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: A report from the women's health initiative: Editorial comment.  192:1458-1460. 2014
  • Re: Comparison between spinal and general anesthesia in percutaneous nephrolithotomy: Editorial comment.  192:1458. 2014
  • Re: Differences in ureteroscopic stone treatment and outcomes for distal, mid-, proximal, or multiple ureteral locations: The clinical research office of the endourological society ureteroscopy global study: Editorial comment.  192:1457-1458. 2014
  • Re: Improving the lens design and performance of a contemporary electromagnetic shock wave lithotripter: Editorial comment.  192:1457-1458. 2014
  • Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.  192:1081-1087. 2014
  • Editorial comment.  191:678. 2014
  • Editorial comment.  191:679. 2014
  • Editorial comment.  191:678-679. 2014
  • Editorial comment.  191:679-680. 2014
  • Inflammatory and tissue remodeling urinary biomarkers before and after mid urethral sling surgery for stress urinary incontinence.  191:703-709. 2014
  • An endogenous pain control system is altered in subjects with interstitial cystitis.  191:364-370. 2014
  • Editorial comment.  191:381. 2014
  • Editorial comment.  191:467. 2014
  • Editorial comment.  191:381-382. 2014
  • Alterations in resting state oscillations and connectivity in sensory and motor networks in women with interstitial cystitis/painful bladder syndrome.  192:947-955. 2014
  • Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: Phase II study in children and adolescents with spina bifida.  191:1389-1395. 2014
  • Editorial comment.  191:1810. 2014
  • Editorial comment.  191:1812. 2014
  • Editorial comment.  191:1811. 2014
  • Editorial comment.  191:1810-1811. 2014
  • Editorial comment.  191:1811-1812. 2014
  • Editorial comment.  191:1812-1813. 2014
  • Effect of aging on storage and voiding function in women with stress predominant urinary incontinence.  192:464-468. 2014
  • High prevalence of screen detected prostate cancer in West Africans: Implications for racial disparity of prostate cancer.  192:730-736. 2014
  • Medical management of kidney stones: AUA guideline.  192:316-324. 2014
  • Military exposure and urinary incontinence among American men.  191:125-129. 2014
  • Re: Age-dependent association between dickkopf-1 and calcium-containing urolithiasis: Editorial comment.  192:440-441. 2014
  • Re: Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion.  191:98. 2014
  • Re: Can obese stone formers follow dietary recommendations?: Editorial comment.  191:994-995. 2014
  • Re: Children with spinal abnormalities have an increased health burden from upper tract urolithiasis: Editorial comment.  192:1809. 2014
  • Re: Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones: Editorial comment.  192:1459. 2014
  • Re: Current practices in percutaneous nephrolithotomy among endourologists: Editorial comment.  192:142-143. 2014
  • Re: Dietary interventions for preventing complications in idiopathic hypercalciuria: Editorial comment.  192:1714-1715. 2014
  • Re: Differences in 24-H urine composition between nephrolithiasis patients with and without diabetes mellitus: Editorial comment.  192:1715. 2014
  • Re: Health-Related Quality of Life (HRQoL) in cystine compared with non-cystine stone formers: Editorial comment.  192:142-143. 2014
  • Re: Heritability of urinary traits that contribute to nephrolithiasis.  192:786-787. 2014
  • Re: In Vitro Anti-Inflammatory Activity of Selected Oxalate-Degrading Probiotic Bacteria: Potential applications in the prevention and treatment of hyperoxaluria: Editorial comment.  192:1130. 2014
  • Re: Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women: Editorial comment.  192:1459. 2014
  • Re: Klotho gene polymorphism of rs3752472 is associated with the risk of urinary calculi in the population of han nationality in Eastern China.  191:97. 2014
  • Re: Management patterns of medicare patients undergoing treatment for upper urinary tract calculi: Editorial comment.  192:143. 2014
  • Re: Persistence of 1,25d-induced hypercalciuria in alendronate treated genetic hypercalciuric stone-forming rats fed a low calcium diet: Editorial comment.  192:615. 2014
  • Re: Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: Transcriptional study in an animal model of hyperoxaluria.  192:999. 2014
  • Re: Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes: Editorial comment.  191:994-995. 2014
  • Re: Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria.  191:97-98. 2014
  • Re: Stone disease in living-related renal donors: Long-term outcomes for transplant donors and recipients: Editorial comment.  192:440-441. 2014
  • Re: The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.  191:98-99. 2014
  • Re: The impact of unplanned postprocedure visits in the management of patients with urinary stones: Editorial comment.  192:1460. 2014
  • Re: Treatment of renal stones with flexible ureteroscopy in preschool age children.  191:1410. 2014
  • Re: Trends and inequalities in the surgical management of ureteral calculi in the USA: Editorial comment.  191:995. 2014
  • Re: Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: A randomized controlled trial comparing DASH (dietary approaches to stop hypertension)-style and low-oxalate diets.  192:786-787. 2014
  • Segmental hyperalgesia to mechanical stimulus in interstitial cystitis/bladder pain syndrome: Evidence of central sensitization.  191:1294-1299. 2014
  • The fluctuation of nocturia in men with lower urinary tract symptoms allocated to placebo during a 12-month randomized, controlled trial.  191:1040-1044. 2014
  • Urological symptoms in a subset of patients with urological chronic pelvic pain syndrome and a polysymptomatic, polysyndromic pattern of presentation.  191:1802-1807. 2014
  • Re: Timing of surgical antibiotic prophylaxis and the risk of surgical site infection.  190:2102. 2013
  • Re: Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria.  190:1269. 2013
  • Re: Ascorbic acid supplements and kidney stone incidence among men: A prospective study.  190:1268-1269. 2013
  • Re: Association of metabolic syndrome traits and severity of kidney stones: Results from a nationwide survey on urolithiasis in Japan.  190:1269-1270. 2013
  • Re: Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis.  190:1437-1438. 2013
  • Re: Renal deterioration index: Preoperative prognostic model for renal functional outcome after treatment of bilateral obstructive urolithiasis in chronic kidney disease patients.  190:901. 2013
  • Re: The impact of RIRS for asymptomatic renal stones in patients undergoing ureteroscopy for a symptomatic ureteral stone.  190:900-901. 2013
  • Re: The surgical management of upper tract stone disease among spinal cord-injured patients.  190:901. 2013
  • Re: Turbulent water coupling in shock wave lithotripsy.  190:900. 2013
  • The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy.  190:923-927. 2013
  • Editorial comment.  190:570. 2013
  • Editorial comment.  190:571. 2013
  • Editorial comment.  190:571. 2013
  • Editorial comment.  190:570-571. 2013
  • Re: Comparison of retrograde intrarenal surgery, shockwave lithotripsy, and percutaneous nephrolithotomy for treatment of medium-sized radiolucent renal stones.  190:157. 2013
  • Re: Standardized flexible ureteroscopic technique to improve stone-free rates.  190:157. 2013
  • Re: Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States.  190:158. 2013
  • Re: Determinants of urolithiasis in patients with intestinal fat malabsorption.  189:2164-2165. 2013
  • Re: Predictive factors and management of steinstrasse after shock wave lithotripsy in pediatric urolithiasis - A multivariate analysis study.  189:2307-2308. 2013
  • Re: The relation between bone and stone formation.  189:2164. 2013
  • Re: Ureteroscopy in pediatric patients with spinal abnormalities.  189:2308-2309. 2013
  • Re: Chaga mushroom-induced oxalate nephropathy: Editorial comment.  189:1768-1769. 2013
  • Re: Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine: Glyoxylate aminotransferase encoded by the polymorphic minor allele: Editorial comment.  189:1769. 2013
  • Re: Incidence of Deflux® calcification masquerading as distal ureteric calculi on ultrasound: Editorial comment.  189:1768. 2013
  • Re: Medullary sponge kidney: State of the art: Editorial comment.  189:1770. 2013
  • Re: Urinary stone differentiation in patients with large body size using dual-energy dual-source computed tomography: Editorial comment.  189:1767. 2013
  • Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment.  189:1203-1213. 2013
  • Impact of obesity on urinary storage symptoms: Results from the FINNO study.  189:1377-1382. 2013
  • Re: Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.  189:1360. 2013
  • Re: Association between body mass index, lipid profiles, and types of urinary stones.  189:1359. 2013
  • Re: Recurrent nephrolithiasis in adults: Comparative effectiveness of preventive medical strategies [Internet].  189:1358-1359. 2013
  • Re: Predictive factors and management of steinstrasse after shock wave lithotripsy in pediatric urolithiasis - A multivariate analysis study.  189:1089-1090. 2013
  • Re: Prospective comparative study of two protocols of antibiotic prophylaxis in percutaneous nephrolithotomy.  189:953-954. 2013
  • Re: Stone comminution correlates with the average peak pressure incident on a stone during shock wave lithotripsy.  189:952. 2013
  • Re: Ureteroscopic treatment of patients with small, painful, non-obstructing renal stones: The small stone syndrome.  189:952-953. 2013
  • Effect of the american urological association annual review course on the results of the urology qualifying examination.  189:658-662. 2013
  • Rapid oxalate determination in blood and synthetic urine using a newly developed oxometer.  189:575-576. 2013
  • Re: Bone metabolism and nutritional status during 30-day head-down tilt bed rest.  189:574. 2013
  • Re: Urinary stone risk and cola consumption.  189:575. 2013
  • Caffeine intake and its association with urinary incontinence in United States men: Results from national health and nutrition examination surveys 2005-2006 and 2007-2008.  189:2170-2174. 2013
  • Can Magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?.  190:2020-2025. 2013
  • Early in life bladder inflammation alters opioid peptide content in the spinal cord and bladder of adult female rats.  189:352-358. 2013
  • Outcomes of infants undergoing robot-assisted laparoscopic pyeloplasty compared to open repair.  190:2221-2227. 2013
  • Re: Calcium regulation of tight junction permeability.  189:173. 2013
  • Re: Differentiation of kidney stones using dual-energy CT with and without a tin filter.  189:172-173. 2013
  • Re: Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: Insights into understanding the rarity of urolithiasis in the black group.  189:171-172. 2013
  • Re: Hyperoxaluric rats do not exhibit Alterations in renal expression patterns of Slc26a1 (SAT1) mRNA or protein.  189:387. 2013
  • Re: The role of oxalobacter formigenes colonization in calcium oxalate stone disease.  190:1268-1270. 2013
  • Re: Urinary metabolic phenotyping the slc26a6 (Chloride-Oxalate Exchanger) null mouse model.  189:386-387. 2013
  • The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery.  189:204-209. 2013
  • Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.  190:1721-1727. 2013
  • Editorial comment.  188:2188. 2012
  • Fulguration for hunner ulcers: Long-term clinical outcomes.  188:2238-2241. 2012
  • Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.  188:2152-2157. 2012
  • Re: Comparison of renal function and metabolic abnormalities of cystine stone patients and calcium oxalate stone patients in China: Editorial comment.  188:2254. 2012
  • Re: Predictive factors of the outcome of extracorporeal shockwave lithotripsy for ureteral stones: Editorial comment.  188:2257. 2012
  • Re: Prevalence of kidney stones in the United States: Editorial comment.  188:2253-2254. 2012
  • Re: Primary prevention of nephrolithiasis is cost-effective for a national healthcare system: Editorial comment.  188:2255. 2012
  • Re: Risk factors for perinephric hematoma formation after shock wave lithotripsy: A matched case-control analysis: Editorial comment.  188:2256-2257. 2012
  • Re: Surgery for primary hyperparathyroidism: Are the consensus guidelines being followed?: Editorial comment.  188:2255-2256. 2012
  • Re: The effects of ambient temperature, humidity and season of year on urine composition in patients with nephrolithiasis: Editorial comment.  188:2252. 2012
  • Re: The impact of dietary calcium and oxalate ratios on stone risk: Editorial comment.  188:2253. 2012
  • Treatment success of retropubic and transobturator mid urethral slings at 24 months.  188:2281-2287. 2012
  • Re: A comparison of the metabolic profiles of diabetic and non-diabetic uric acid stone formers.  188:1202. 2012
  • Re: Improving the interpretation of ureteroscopic biopsies: Use of Bouin's fixative.  188:1202. 2012
  • Re: Nephrolithiasis in medullary sponge kidney: Evaluation of clinical and metabolic features.  188:1202-1203. 2012
  • Re: Osteoporosis in paediatric patients with spina bifida.  188:1340. 2012
  • Re: Urine risk factors in children with calcium kidney stones and their siblings.  188:1339. 2012
  • Re: Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic.  188:1201. 2012
  • Re: Abdominal fat distribution on computed tomography predicts ureteric calculus fragmentation by shock wave lithotripsy.  188:848. 2012
  • Re: Laser-guided percutaneous kidney access with the uro dyna-CT: First experience of three-dimensional puncture planning with an ex vivo model.  188:1045. 2012
  • Re: Renal haemorrhage risk after extracorporeal shockwave lithotripsy: Results from the Japanese diagnosis procedure combination database.  188:848-849. 2012
  • Re: Slc13a1 and Slc26a1 KO models reveal physiological roles of anion transporters.  188:1044. 2012
  • Patient related factors associated with long-term urinary continence after burch colposuspension and pubovaginal fascial sling surgeries.  188:485-489. 2012
  • Re: Factors influencing urologist treatment preference in surgical management of stone disease.  188:455. 2012
  • Re: Laparoscopic anatrophic nephrolithotomy: Developments of the technique in the era of minimally invasive surgery.  188:456-457. 2012
  • Re: The use of triclosan eluting stents effectively reduces ureteral stent symptoms: A prospective randomized trial.  188:458. 2012
  • Re: Ureteroscopy for transplant lithiasis.  188:455-456. 2012
  • Re: Urinary tract infections and post-operative fever in percutaneous nephrolithotomy.  188:457. 2012
  • Re: Comparison of percutaneous nephrolithotomy and retrograde flexible nephrolithotripsy for the management of 2-4 cm stones: A matched-pair analysis.  188:160. 2012
  • Re: Decreased expression of vitamin K epoxide reductase complex subunit 1 in kidney of patients with calcium oxalate urolithiasis.  188:156-157. 2012
  • Re: Effects of drinking water quality on urinary parameters in men with and without urinary tract stones.  188:155. 2012
  • Re: Effects of vitamin e ingestion on plasma and urinary risk factors for calcium oxalate urolithiasis in two population groups having different stone-risk profiles: Evidence of different physiological handling mechanisms.  188:155-156. 2012
  • Re: Evaluation of the optimal frequency of and pretreatment with shock waves in patients with renal stones.  188:158-159. 2012
  • Re: Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi.  188:159. 2012
  • Re: Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.  188:157-158. 2012
  • Re: Prevalence and metabolic abnormalities of vitamin D-inadequate patients presenting with urolithiasis to a tertiary stone clinic.  188:157. 2012
  • Re: Shock wave lithotripsy and diabetes mellitus: A population-based cohort study.  188:160-161. 2012
  • Urological laparoendoscopic single site surgery: Multi-institutional analysis of risk factors for conversion and postoperative complications.  187:1989-1994. 2012
  • Re: Are stone protocol computed tomography scans mandatory for children with suspected urinary calculi?.  187:1852-1853. 2012
  • Re: Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells.  187:1927-1928. 2012
  • Re: Desensitization in HLA-incompatible kidney recipients and survival.  187:1766-1767. 2012
  • Re: Hydroxyproline metabolism in mouse models of primary hyperoxaluria.  187:1928. 2012
  • Re: Hypercalciuria associated with high dietary protein intake is not due to acid load.  187:1928-1929. 2012
  • Re: Nephrocalcinosis and urolithiasis in children.  187:1853. 2012
  • 5-year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence.  187:1324-1330. 2012
  • Re: Are stone protocol computed tomography scans mandatory for children with suspected urinary calculi?.  187:1436-1437. 2012
  • Re: Ethylene glycol induces calcium oxalate crystal deposition in malpighian tubules: A drosophila model for nephrolithiasis/urolithiasis.  187:1299-1300. 2012
  • Re: Hyperoxaluria: A gut-kidney axis?.  187:1299. 2012
  • Re: Klotho: A novel regulator of calcium and phosphorus homeostasis.  187:1298-1299. 2012
  • Re: Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.  187:926. 2012
  • Re: Changing composition of renal calculi in patients with musculoskeletal anomalies.  187:927-928. 2012
  • Re: Defining hypercalciuria in nephrolithiasis.  187:925. 2012
  • Re: Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria.  187:1055-1056. 2012
  • Re: Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population.  187:928. 2012
  • Re: Primary hyperoxaluria type III gene HOGA1 (Formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.  187:926-927. 2012
  • Re: Anatomical variation between the prone, supine, and supine oblique positions on computed tomography: Implications for percutaneous nephrolithotomy access.  187:533. 2012
  • Re: Outcomes of long-term follow-up of patients with conservative management of asymptomatic renal calculi.  187:533-534. 2012
  • Re: Tamsulosin and doxazosin as adjunctive therapy following shock-wave lithotripsy of renal calculi: Randomized controlled trial.  187:534. 2012
  • Re: Twenty-year prevalence of diabetes mellitus and hypertension in patients receiving shock-wave lithotripsy for urolithiasis.  187:535. 2012
  • Impact of nutritional factors on incident kidney stone formation: A report from the WHI OS.  187:1645-1650. 2012
  • Quality of lymphadenectomy is equivalent with robotic and open cystectomy using an extended template.  187:1200-1205. 2012
  • Re: Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.  187:354-355. 2012
  • Re: Inhibitory effect of rutin and curcumin on experimentally-induced calcium oxalate urolithiasis in rats.  187:354. 2012
  • Re: Novel stone-magnetizing microparticles: In vitro toxicity and biologic functionality analysis.  187:353-354. 2012
  • Re: Oxalate-degrading capacities of lactic acid bacteria in canine feces.  187:355. 2012
  • Renal cell carcinoma metastatic to the ovary.  188:603-604. 2012
  • Stuart B. Bauer.  188:1409-1410. 2012
  • Re: Body fat composition and occurrence of kidney stones in hypercalciuric children.  186:2412. 2011
  • Re: Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: A prospective randomized controlled trial.  186:2291-2292. 2011
  • Re: Predictors for negative ureteroscopy in the management of upper urinary tract stone disease.  186:2291. 2011
  • Re: Randomized prospective trial comparing immediate versus delayed ureteroscopy for patients with ureteral calculi and normal renal function who present to the emergency department.  186:2292. 2011
  • Re: Reduction of plasma oxalate levels by oral application of oxalobacter formigenes in 2 patients with infantile oxalosis.  186:2411-2412. 2011
  • Re: Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers.  186:1916-1917. 2011
  • Re: Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients.  186:1336. 2011
  • Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery.  186:597-603. 2011
  • Do chief resident scores on the in-service examination predict their performance on the american board of urology qualifying examination?.  186:634-637. 2011
  • Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008.  186:589-593. 2011
  • Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design: Editorial comment.  186:345. 2011
  • Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with oxalobacter.  186:346. 2011
  • Impact of dietary calcium and oxalate, and oxalobacter formigenes colonization on urinary oxalate excretion.  186:135-139. 2011
  • A comparative study of artificial neural network and multivariate regression analysis to analyze optimum renal stone fragmentation by extracorporeal shock wave lithotripsy.  185:2187. 2011
  • Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.  185:1747. 2011
  • Re.: Nephrolithiasis-associated bone disease: pathogenesis and treatment options.  185:1749. 2011
  • Editorial comment.  185:1312. 2011
  • Prevalence of nocturia in United States men: Results from the national health and nutrition examination survey.  185:998-1002. 2011
  • DASH-style diet and 24-hour urine composition.  185:548. 2011
  • Determination of renal stone composition with dual-energy CT: In vivo analysis and comparison with x-ray diffraction.  185:550. 2011
  • Re: metabolism of fructose to oxalate and glycolate.  185:548-549. 2011
  • Single focus prostate cancer: Pathological features and erg fusion status.  185:489-494. 2011
  • A comparative study of clinical value of single B-mode ultrasound guidance and B-Mode combined with color Doppler ultrasound guidance in mini-invasive percutaneous nephrolithotomy to decrease hemorrhagic complications.  185:184. 2011
  • Clinical significance of uric acid dihydrate in urinary stones.  185:1747-1748. 2011
  • Endovascular covered stenting for the management of post-percutaneous nephrolithotomy renal pseudoaneurysm: A case report: Editorial comment.  185:936-937. 2011
  • Factors affecting the success of ureteroscopy in management of ureteral stone diseases in children.  185:277-278. 2011
  • Heterogeneity in the reporting of disease characteristics and treatment outcomes in studies evaluating treatments for nephrolithiasis: Editorial comment.  185:935-936. 2011
  • Is a safety wire necessary during routine flexible ureteroscopy?: Editorial comment.  185:937. 2011
  • Laterality of nephrocalcinosis in kidney stone formers with severe hypocitraturia.  185:2186-2187. 2011
  • Meatotomy using local anesthesia with and without penile block.  185:377-378. 2011
  • Metabolism of fructose to oxalate and glycolate.  185:548-549. 2011
  • Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction.  185:185-186. 2011
  • Postmenopausal hormone use and the risk of Nephrolithiasis: Results from the women's health initiative hormone therapy trials.  185:1749-1750. 2011
  • Re: Clinical Practice. Calcium Kidney Stones: Editorial Comment.  185:1313. 2011
  • Re: Does Urinary Stone Composition and Morphology Help for Prediction of Primary Hyperparathyroidism?: Editorial Comment.  185:1313-1314. 2011
  • Re: Ex-vivo ureteroscopy at the time of live donor nephrectomy.  186:2340-2341. 2011
  • Re: Fasting and postprandial spot urine calcium-to-creatinine ratios do not detect hypercalciuria.  186:1338. 2011
  • Re: Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers.  186:1337. 2011
  • Re: Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease: Editorial Comment.  185:1313. 2011
  • Re: Quantification of urinary stone volume: Attenuation threshold-based CT method-A technical note.  186:1339. 2011
  • Re: The role of salt abuse on risk for hypercalciuria.  186:1337-1338. 2011
  • Renal impairment in children with cystic fibrosis.  185:278. 2011
  • Single nucleotide polymorphisms in the human Na+-dicarboxylate cotransporter affect transport activity and protein expression: Editorial comments.  186:347-348. 2011
  • This month in pediatric urology.  185:2007-2008. 2011
  • This month in pediatric urology.  186:2145-2146. 2011
  • This month in pediatric urology.  186:365-366. 2011
  • Tumor volume threshold of insignificant prostate cancer-was Dr. Stamey Right all along?.  185:10-11. 2011
  • Nephrogenic adenoma of the bladder.  184:2535-2536. 2010
  • Urolithiasis/endourology.  184:2383-2388. 2010
  • Editorial comments.  184:2205-2206. 2010
  • Intrarenal pressures generated during deployment of various antiretropulsion devices in an Ex vivo porcine model.  184:2208. 2010
  • Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.  184:1958-1962. 2010
  • Editorial comment.  184:1821. 2010
  • Editorial comment.  184:1650. 2010
  • Laparoendoscopic single-site pfannenstiel versus standard laparoscopic donor nephrectomy.  184:1441. 2010
  • Opioid blockade and inflammation reveal estrous cycle effects on visceromotor reflexes evoked by bladder distention.  184:1529-1535. 2010
  • Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux.  184:1594-1597. 2010
  • Effect of weight loss on urinary incontinence in overweight and obese women: Results at 12 and 18 months.  184:1005-1010. 2010
  • Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model.  184:1220. 2010
  • Prevalence of urinary incontinence in men: Results from the national health and nutrition examination survey.  184:1022-1027. 2010
  • Editorial comment.  184:584-587. 2010
  • Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.  184:598-603. 2010
  • This Month in Pediatric Urology.  183:2113-2114. 2010
  • Repeat Partial Nephrectomy on the Solitary Kidney: Surgical, Functional and Oncological Outcomes.  183:1719-1724. 2010
  • Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer Development.  183:1604-1610. 2010
  • Screening Agents for Preventive Efficacy in a Bladder Cancer Model: Study Design, End Points, and Gefitinib and Naproxen Efficacy.  183:1598-1603. 2010
  • This Month in Pediatric Urology.  183:1272-1273. 2010
  • Effect of Estrogen on Bladder Nociception in Rats.  183:1201-1205. 2010
  • How Do Commonly Performed Lymphadenectomy Templates Influence Bladder Cancer Nodal Stage?.  183:499-504. 2010
  • Robotic Radical Cystectomy for Bladder Cancer: Surgical and Pathological Outcomes in 100 Consecutive Cases.  183:510-515. 2010
  • The Impact of Obesity on Urinary Incontinence Symptoms, Severity, Urodynamic Characteristics and Quality of Life.  183:622-628. 2010
  • This Month in Pediatric Urology.  183:414-415. 2010
  • Candidate urinary biomarker discovery in ureteropelvic junction obstruction.  184:409-410. 2010
  • Editorial Comment.  183:157. 2010
  • Editorial Comment.  183:86. 2010
  • Nongerm Cell Malignancies in Testicular Germ Cell Tumors.  183:327-328. 2010
  • Timer watch assisted urotherapy in children.  184:1243-1244. 2010
  • Urodynamic studies are recommended in children with central nervous system tumors.  184:2225-2226. 2010
  • Obesity and Urinary Incontinence: Epidemiology and Clinical Research Update.  182. 2009
  • Risk Factors Associated With Urge Incontinence After Continence Surgery.  182:2805-2809. 2009
  • This Month in Pediatric Urology.  182:2548-2549. 2009
  • This Month in Pediatric Urology.  182:1247-1248. 2009
  • Radiation Cystitis.  182:1172-1173. 2009
  • This Month in Pediatric Urology.  182:416-417. 2009
  • Topoisomerase II α Status in Renal Medullary Carcinoma: Immuno-Expression and Gene Copy Alterations of a Potential Target of Therapy.  182:735-740. 2009
  • Ice Water Testing Reveals Hypersensitivity in Adult Rats That Experienced Neonatal Bladder Inflammation: Implications for Painful Bladder Syndrome/Interstitial Cystitis.  182:337-342. 2009
  • KTP Laser Nerve Sparing Radical Prostatectomy: Comparison of Ultrasonic and Cold Scissor Dissection on Cavernous Nerve Function.  181:2760-2766. 2009
  • This Month in Pediatric Urology.  181:2406-2407. 2009
  • Complications in Women Undergoing Burch Colposuspension Versus Autologous Rectus Fascial Sling for Stress Urinary Incontinence.  181:2192-2197. 2009
  • A NO CARBOHYDRATE DIET SIGNIFICANTLY PROLONGS SURVIVAL IN A PROSTATE CANCER XENOGRAFT MODEL VIA IGF-1 AND GLOBAL GENE EXPRESSION CHANGES.  181:47-47. 2009
  • Long-Term Outcomes in Younger Men Following Permanent Prostate Brachytherapy.  181:1665-1671. 2009
  • Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy.  181:1672-1677. 2009
  • This Month in Pediatric Urology.  181:1523-1524. 2009
  • Epigenetic Reprogramming: A Possible Etiological Factor in Bladder Pain Syndrome/Interstitial Cystitis?.  181:980-984. 2009
  • Phosphorylated H2AX in Noninvasive Low Grade Urothelial Carcinoma of the Bladder: Correlation With Tumor Recurrence.  181:1387-1392. 2009
  • This Month in Pediatric Urology.  181:438-439. 2009
  • Editorial Comment.  181:1074-1075. 2009
  • Editorial comment.  182:1682. 2009
  • Prevalence of Hyperoxaluria After Bariatric Surgery.  181:161-166. 2009
  • p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy.  182:907-913. 2009
  • This Month in Pediatric Urology.  180:2282-2283. 2008
  • This Month in Pediatric Urology.  180:1212-1213. 2008
  • The Common in Boston.  180:439-440. 2008
  • This Month in Pediatric Urology.  180:427-428. 2008
  • Feasibility and Outcomes of Repeat Partial Nephrectomy.  180:89-93. 2008
  • Refractory Idiopathic Urge Urinary Incontinence and Botulinum A Injection.  180:217-222. 2008
  • Prolapse and Incontinence Surgery in Older Women.  179:2111-2118. 2008
  • This Month in Pediatric Urology.  179:2079-2080. 2008
  • Prospective Randomized Trial Comparing Shock Wave Lithotripsy and Ureteroscopy for Lower Pole Caliceal Calculi 1 cm or Less.  179. 2008
  • Prostate Specific Antigen Versus Prostate Specific Antigen Density as a Prognosticator of Pathological Characteristics and Biochemical Recurrence Following Radical Prostatectomy.  179:1780-1784. 2008
  • Saturation Technique Does Not Decrease Cancer Detection During Followup After Initial Prostate Biopsy.  179:1746-1750. 2008
  • Pathological Aggressiveness of Prostatic Carcinomas Related to RNASEL R462Q Allelic Variants.  179:1344-1348. 2008
  • Population Based Study of Incidence and Predictors of Urinary Incontinence in Black and White Older Adults.  179:1449-1454. 2008
  • This Month in Pediatric Urology.  179:1218-1219. 2008
  • Urodynamic Measures Do Not Predict Stress Continence Outcomes After Surgery for Stress Urinary Incontinence in Selected Women.  179:1470-1474. 2008
  • Living Renal Donor Allograft Lithiasis: A Review of Stone Related Morbidity in Donors and Recipients.  179:832-836. 2008
  • Predictors of Treatment Failure 24 Months After Surgery for Stress Urinary Incontinence.  179:1024-1030. 2008
  • Prostate Cancer Volume at Biopsy Predicts Clinically Significant Upgrading.  179:896-900. 2008
  • Repeat vasectomy reversal yields high success rates.  179:648. 2008
  • Predictors of success with postoperative voiding trials after a mid urethral sling procedure.  179:600-604. 2008
  • Salvage Partial Nephrectomy for Hereditary Renal Cancer: Feasibility and Outcomes.  179:67-70. 2008
  • This month in pediatric urology.  179:398-399. 2008
  • 2007 Guideline for the Management of Ureteral Calculi.  178:2418-2434. 2007
  • Impact of Patient Age on Biochemical Recurrence Rates Following Radical Prostatectomy.  178:1933-1938. 2007
  • Variability of Oxalobacter Formigenes and Oxalate in Stool Samples.  178:2186-2190. 2007
  • Importance of Tumor Location in Patients With High Preoperative Prostate Specific Antigen Levels (Greater Than 20 ng/ml) Treated With Radical Prostatectomy.  178:1311-1315. 2007
  • Subclassification of Clinical Stage T1 Prostate Cancer: Impact on Biochemical Recurrence Following Radical Prostatectomy.  178:1277-1281. 2007
  • Lower Urinary Tract Symptoms, Quality of Life and Pelvic Organ Prolapse: Irritative Bladder and Obstructive Voiding Symptoms in Women Planning to Undergo Abdominal Sacrocolpopexy for Advanced Pelvic Organ Prolapse.  178:965-969. 2007
  • The Relationship Between Anxiety and Time to Treatment for Patients With Prostate Cancer on Surveillance.  178:826-832. 2007
  • Anesthesia for Laparoscopic Donor Nephrectomy: Is Nitrous Oxide Contraindicated?.  178:225-227. 2007
  • Computerized Tomographic Angiography for Renal Donor Evaluation Leads to a Higher Exclusion Rate.  177:1826-1829. 2007
  • Early Prostate Cancer Antigen Expression in Predicting Presence of Prostate Cancer in Men With Histologically Negative Biopsies.  177:1736-1740. 2007
  • A no-carbohydrate diet significantly delays prostate cancer growth in an animal model.  177:50-50. 2007
  • End Cutaneous Ureterostomy for the Management of Severe Hydronephrosis.  177:1501-1504. 2007
  • Randomized, Controlled Trial of Spaced Education to Urology Residents in the United States and Canada.  177:1481-1487. 2007
  • Editorial Comment.  177:101. 2007
  • Editorial Comments.  178:1756-1757. 2007
  • Incontinence Following Bladder Neck Reconstruction-Is There a Role for Endoscopic Management?.  177:302-306. 2007
  • The Effects of Spinal Cord Injury on Psychogenic Sexual Arousal in Males.  177:247-251. 2007
  • Primary Carcinoid Tumors of the Kidney.  176:2359-2366. 2006
  • Endoscopic Injection of Dextranomer/Hyaluronic Acid Copolymer to Correct Vesicoureteral Reflux Following Failed Ureteroneocystostomy.  176:1861-1863. 2006
  • Re: The Use of Bowel for Ureteral Replacement for Complex Ureteral Reconstruction: Long-Term Results. B. I. Chung, K. J. Hamawy, L. N. Zinman and J. A. Libertino J Urol, 175: 179-184, 2006.  176:410-411. 2006
  • Gene expression profiling of prostate cancers from obese men identified HMGCS2 as a novel biomarker of aggressive prostate cancer and as a potential therapeutic target.  175:79-79. 2006
  • Real-time transrectal ultrasound guidance during laparoscopic radical prostatectomy: Impact on surgical margins.  175:1304-1310. 2006
  • Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.  175:485-488. 2006
  • Multi-institutional validation of vasectomy reversal predictor.  175:247-249. 2006
  • Preoperative biofeedback assisted behavioral training to decrease post-prostatectomy incontinence: A randomized, controlled trial.  175:196-201. 2006
  • Bladder rehabilitation in children with spina bifida: State-of-the- "art".  173:1850-1851. 2005
  • Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations..  173:1991-2000. 2005
  • Dietary oxalate loads and renal oxalate handling.  174:943-947. 2005
  • Laparoscopic partial nephrectomy for cystic masses.  174:614-619. 2005
  • Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.  174:1020-1023. 2005
  • Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis.  174:1832-1836. 2005
  • Potassium-titanyl-phosphate laser laparoscopic partial nephrectomy without hilar clamping in the survival calf model.  174:1110-1114. 2005
  • Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less.  173:2005-2009. 2005
  • Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis.  173:1983-1987. 2005
  • Vasovasostomy in the convoluted vas deferens: Indications and outcomes.  173:540-542. 2005
  • Water jet assisted laparoscopic partial nephrectomy without hilar clamping in the calf model.  174:317-321. 2005
  • Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes..  172:1809-1812. 2004
  • INCREASED RISK OF BLADDER CANCER ASSOCIATED WITH A GLUTATHIONE PEROXIDASE 1 CODON 198 VARIANT.  172:728-732. 2004
  • Supplement-use among prostate cancer survivors.  171:122-122. 2004
  • Donor nephrectomy: A comparison of techniques and results of open, hand assisted and full laparoscopic nephrectomy.  171:40-43. 2004
  • Laparoscopic extended pelvic lymphadenectomy for bladder cancer: Technique and initial outcomes.  172:1809-1812. 2004
  • Percutaneous nephrostolithotomy: Predictors of length of stay.  172:1351-1354. 2004
  • Reliable visceromotor responses are evoked by noxious bladder distention in mice.  171:1704-1708. 2004
  • Bladder neck cinch for pediatric neurogenic outlet deficiency.  170:1501-1504. 2003
  • Arginine vasopressin and nocturnal polyuria in older adults with frequent nighttime voiding.  170:480-484. 2003
  • Arginine vasopressin and nocturnal polyuria in older adults with frequent nighttime voiding..  170:480-484. 2003
  • Computerized tomography guided access for percutaneous nephrostolithotomy.  170:45-47. 2003
  • Percutaneous management of calculi within horseshoe kidneys.  170:48-51. 2003
  • Pregnancy outcomes after vasectomy reversal for female partners 35 years old or older.  169:2250-2252. 2003
  • Management of intrinsic sphincteric deficiency in women.  169:1662-1669. 2003
  • Transvaginal ultrasound for the diagnosis of urethral diverticulum.  169:1395-1397. 2003
  • Successful renal transplantation in children with posterior urethral valves.  170:2402-2404. 2003
  • Cystic ectasia of the rete testis: clinical and radiographic features..  168:1436-1438. 2002
  • Cystic ectasia of the rete testis: Clinical and radiographic features.  168:1436-1438. 2002
  • Prostate abscess following intravesical bacillus calmette-guerin treatment.  167:251. 2002
  • The impact of cystinuria on renal function.  168:27-30. 2002
  • UroLume stents: Lessons learned.  167:2477-2480. 2002
  • Accuracy of renal-bladder ultrasonography as a screening method to suggest posterior urethral valves..  165:2245-2247. 2001
  • Characterization of pressor and visceromotor reflex responses to bladder distention in rats: Sources of variability and effect of analgesics.  165:968-974. 2001
  • Complete urethral disruption without pelvic fracture.  166:1425. 2001
  • Fatty acid synthase: An early molecular marker of progression of prostatic adenocarcinoma to androgen independence.  165:1027-1032. 2001
  • Lower pole I: A prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis - Initial results.  166:2072-2080. 2001
  • Pseudotumorous renal involvement of sarcoidosis.  165:895. 2001
  • Re: Survey results on medical and surgical followup of patients with vesicoureteral reflux from american association of pediatrics, section on urology members [4] (multiple letters).  166:1403. 2001
  • Significant medical pathology discovered during a male infertility evaluation.  166:178-180. 2001
  • Survey results on medical and surgical followup of patients with vesicoureteral reflux from american association of pediatrics, section on urology members.  165:559-563. 2001
  • The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen.  165:294-300. 2001
  • Urological outcome of patients with cervical and upper thoracic myelomeningocele.  164:962-964. 2000
  • Urological outcome of patients with cervical and upper thoracic myelomeningocele..  164:962-964. 2000
  • Editorial: Posterior urethral valves and the 11th commandment.  164:149-150. 2000
  • Geographic variation and environmental risk factors for the incidence of initial kidney stones in patients with spinal cord injury.  164:21-26. 2000
  • Laparoscopic lymphocelectomy: A multi-institutional analysis.  163:1096-1099. 2000
  • Prediction of spontaneous ureteral calculous passage by an artificial neural network.  164:326-328. 2000
  • Urethral slough: A rare and previously unreported complication of intravesical mitomycin.  164:1305. 2000
  • Pediatric inflammatory bladder tumors: myofibroblastic and eosinophilic subtypes..  162:1424-1429. 1999
  • Tunica vaginalis onlay urethroplasty as a salvage repair..  162:1146-1147. 1999
  • Varicocele is associated with elevated spermatozoal reactive oxygen species production and diminished seminal plasma antioxidant capacity..  161:1831-1834. 1999
  • Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma.  161:945-949. 1999
  • Ep-CAM levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.  162:1462-1466. 1999
  • Pediatric inflammatory bladder tumors: Myofibroblastic and eosinophilic subtypes.  162:1424-1429. 1999
  • Varicocele is associated with elevated spermatozoal reactive oxygen species production and diminished seminal plasma antioxidant capacity.  161:1831-1834. 1999
  • Glyoxylate synthesis, and its modulation and influence on oxalate synthesis..  160:1617-1624. 1998
  • Outcome and cost analysis of operative versus nonoperative management of neonatal multicystic dysplastic kidneys..  160:1207-1211. 1998
  • Renal transplantation in children with posterior urethral valves revisited: a 10-year followup..  160:1201-1203. 1998
  • Editorial: Insights into the pathophysiology and treatment of patients with calcium oxalate nephrolithiasis.  159:1457-1458. 1998
  • Glyoxylate synthesis, and its modulation and influence on oxalate synthesis.  160:1617-1624. 1998
  • Quality of life in metastatic prostate cancer among men of lower socioeconomic status: Feasibility and criterion related validity of 3 measures.  160:1765-1769. 1998
  • Contralateral vesicoureteral reflux after simple and tapered unilateral ureteroneocystostomy revisited..  158:1219-1220. 1997
  • Two-stage Fowler-Stephens orchiopexy with laparoscopic clipping of the spermatic vessels..  158:1205-1207. 1997
  • Contralateral vesicoureteral reflux after simple and tapered unilateral ureteroneocystostomy revisited.  158:1219-1220. 1997
  • Critical analysis of the clinical presentation of acute scrotum: A 9- year experience at a single institution.  158:1198-1200. 1997
  • Discussion: Two-stage Fowler-Stephens orchiopexy with laparoscopic clipping of the spermatic vessels.  158:1208-1209. 1997
  • Evidence for altered proliferative ability of progenitors of urothelial cells in interstitial cystitis.  158:248-252. 1997
  • Intravesical morphine analgesia after bladder surgery.  157:1407-1409. 1997
  • The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretion.  158:34-37. 1997
  • Two-stage fowler-stephens orchiopexy with laparoscopic clipping of the spermatic vessels.  158:1205-1207. 1997
  • Ureteral stones clinical guidelines panel summary report on the management of ureteral calculi.  158:1915-1921. 1997
  • Vasoepididymostomy for vasectomy reversal: A critical assessment in the era of intracytoplasmic sperm injection.  158:467-470. 1997
  • Is radiographic evaluation of the chest necessary following flank surgery?.  155:849-851. 1996
  • An unusual pelvic pseudotumor: a case report..  155:644. 1996
  • Acute spermatic cord torsion alters the microcirculation of the contralateral testis.  155:350-354. 1996
  • An unusual pelvic pseudotumor: A case report.  155:644. 1996
  • Is radiographic evaluation of the chest necessary following flank surgery?.  155:849-851. 1996
  • Nephrolithiasis in patients with urinary diversion..  155:69-70. 1996
  • Re: Family pattern of idiopathic hypercalciuria and its subtypes.  156:2012. 1996
  • The Le Bag orthotopic urinary diversion.  156:926-930. 1996
  • Postoperative hospitalization of children undergoing cross-trigonal ureteroneocystostomy..  154:794-796. 1995
  • Genetic Factors in Calcium Oxalate Stone Disease.  153:301-307. 1995
  • Lewis Y Antigen as Detected by the Monoclonal Antibody BR96 is Expressed Strongly in Prostatic Adenocarcinoma.  153:1572-1574. 1995
  • Postoperative Hospitalization of Children Undergoing Cross-Trigonal Ureteroneocystostomy.  154:794-796. 1995
  • The Contemporary Role of Extra-anatomical Surgical Renal Revascularization in Patients with Atherosclerotic Renal Aretery Disease.  153:1798-1802. 1995
  • Changing incidence and etiology of iatrogenic ureteral injuries..  152:2240-2246. 1994
  • Changing incidence and etiology of iatrogenic ureteral injuries.  152:2240-2246. 1994
  • Nephrolithiasis clinical guidelines panel summary report on the management of staghorn calculi.  151:1648-1651. 1994
  • Obliterative pyeloureteritis: A complication of stone disease in patients with urinary conduit diversion.  150:961-965. 1993
  • The use of iothalamate meglumine 17.2% as an effective testing medium in lower urinary tract urodynamic assessment of children.  149:92-93. 1993
  • Urological dysfunction in patients with diastematomyelia.  149:1503-1505. 1993
  • Tetrodotoxin protects against acute ischemic renal failure in the rat.  147:519-522. 1992
  • The effect of medium-fill and slow-fill saline cystometry on detrusor pressure in infants and children with myelodysplasia.  147:444-446. 1992
  • A comparison of anatrophic nephrolithotomy and percutaneous nephrolithotomy with and without extracorporeal shock wave lithotripsy for management of patients with staghorn calculi.  145:710-714. 1991
  • Intraoperative renal ultrasonography: A useful adjunct to partial nephrectomy.  146:1218-1220. 1991
  • Leukemic relapse presenting with ureteral obstruction caused by granulocytic sarcoma.  146:1354-1355. 1991
  • Normative patterns of diurnal urination across 6 age decades.  145:728-731. 1991
  • Renal mucormycosis: A case report and review of the literature.  145:1242-1244. 1991
  • Renal transplantation in children with posterior urethral valves.  146:1585-1587. 1991
  • Short-term and long-term changes in renal function after donor nephrectomy.  145:11-13. 1991
  • Spontaneous perinephric hemorrhage: Imaging and management.  145:468-471. 1991
  • The expression of epidermal growth factor receptor on human bladder cancer: Potential use in radioimmunoscintigraphy.  146:227-231. 1991
  • Augmentation cystoplasty complicated by postoperative ventriculoperitoneal shunt infection.  144:955-956. 1990
  • Augmentation cystoplasty complicated by postoperative ventriculoperitoneal shunt infection: Reply by authors.  144:956. 1990
  • Comparison of antigen expression on normal urothelial cells in tissue section and tissue culture.  144:1288-1292. 1990
  • Duraphase penile prosthesis - Results of clinical trials in 63 patients.  143:518-519. 1990
  • Ureteral obstruction due to blood clot following percutaneous renal biopsy: Resolution with intraureteral streptokinase.  143:113-115. 1990
  • The role of open stone surgery since extracorporeal shock wave lithotripsy..  142:263-267. 1989
  • Lower pole ureteropelvic junction obstruction and incomplete renal duplication..  141:896-899. 1989
  • Neoadjuvant treatment of stages T2 to T4 bladder cancer with cis-platinum, cyclophosphamide and doxorubicin..  141:849-852. 1989
  • Renal angiomyolipoma associated with lymph node involvement and renal cell carcinoma in patients with tuberous sclerosis..  141:930-932. 1989
  • Effects of shock waves on the rat ovary..  141:666-669. 1989
  • Effects of shock waves on the rat ovary.  141:666-669. 1989
  • Lower pole ureteropelvic junction obstruction and incomplete renal duplication.  141:896-899. 1989
  • Neoadjuvant treatment of stages T2 to T4 bladder cancer with cis-platinum, cyclophosphamide and doxorubicin.  141:849-852. 1989
  • Renal angiomyolipoma associated with lymph node involvement and renal cell carcinoma in patients with tuberous sclerosis.  141:930-932. 1989
  • Selective elevation of urinary enzyme levels after extracorporeal shock wave lithotripsy.  142:687-690. 1989
  • The role of open stone surgery since extracorporeal shock wave lithotripsy.  142:263-267. 1989
  • Ureteral obstruction secondary to a vena caval clip..  140:1014-1015. 1988
  • Ureteral obstruction secondary to a vena caval clip.  140:1014-1015. 1988
  • Genitourinary abnormalities associated with the Smith-Lemli-Opitz syndrome.  137:719-721. 1987
  • Iatrogenic dilatation of the upper urinary tract during radiographic evaluation of patients with spinal cord injury.  135:78-82. 1986
  • Initial bladder management in spinal cord injury: Does it make a difference?.  135:523-527. 1986
  • Postoperative anatrophic nephrolithotomy bleeding.  135:1153-1156. 1986
  • Effective renal plasma flow: Clinical significance after spinal cord injury.  133:758-761. 1985
  • Long-term followup of renal function after spinal cord injury.  134:510-513. 1985
  • Pediatric anatrophic nephrolithotomy.  133:233-235. 1985
  • Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients.  134:514-516. 1985
  • Clear cell adenocarcinoma of the urethra.  131:540-541. 1984
  • Effect of skeletal muscle relaxants on bladder smooth muscle.  132:372-375. 1984
  • Long-term evaluation of the inflatable penile prosthesis.  131:670-673. 1984
  • Renal function after acute and chronic spinal cord injury.  131:439-445. 1984
  • The risk of renal calculi in spinal cord injury patients.  131:857-859. 1984
  • Failure of antibody-coated bacteria and bladder washout tests to localize infection in spinal cord injury patients.  130:729-732. 1983
  • Transurethral removal of migrated indwelling ureteral stents: A new technique.  130:765. 1983
  • Bilateral dislocation of rear tip extenders from the inflatable penile prosthesis.  128:1317-1318. 1982
  • A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.  125:191-195. 1981
  • Comprehensive renal scintillation procedures in spinal cord injury: Comparison with excretory urography.  126:10-13. 1981
  • Intraoperative roentgenography in the surgical removal of renal calculi.  125:284-286. 1981
  • Adjuvant surgical techniques in the removal of staghorn calculi.  123:342-344. 1980
  • Upward migration of indwelling ureteral stents.  122:249-250. 1979
  • Radionuclide kidney function evaluation in the management of urolithiasis.  120:16-20. 1978
  • Management of severe hydroureteronephrosis in infants and young children.  115:587-590. 1976
  • Solitary leiomyomas arising from the tunica dartos scroti.  116:69-71. 1976
  • International Standard Serial Number (issn)

  • 0022-5347
  • Electronic International Standard Serial Number (eissn)

  • 1527-3792